Abstract:The special CAD system "BONENAVI" trained with a Japanese database appears to have significant potential in assisting physicians in their clinical routine. However, an improved CAD system depending on the primary lesion of the cancer is required to decrease the proportion of false-positive findings.
“…The file format issue is relevant when comparing data among sites and in serial scans if different file formats are used.The diagnostic properties of the computer-aided analysis program showed sensitivities and specificities of 90-100% with DICOM format files and 69-88% with Interfile formats. The high sensitivities and specificities are in line with previous reports[9,10,12,17]. Most studies with EXINI Bone BSI have been performed in patients with metastatic disease in whom the prevalence of metastasis varied from 15 to 40%[10,12,15].…”
supporting
confidence: 86%
“…The high sensitivities and specificities are in line with previous reports[9,10,12,17]. Most studies with EXINI Bone BSI have been performed in patients with metastatic disease in whom the prevalence of metastasis varied from 15 to 40%[10,12,15]. In clinical practice, the true reference is seldom known and the PPV and NPVs are of major importance.…”
supporting
confidence: 82%
“…EXINI Bone BSI is one such system with solid documentation [9][10][11][12]. The validation of computer-assisted software has mostly been performed in mixed patient populations with different types of cancer, in patients with a high prevalence for metastatic disease, in retrospective settings, and with limited sample sizes.…”
EXINI Bone(BSI) showed high sensitivity and specificity for bone metastasis in patients with newly diagnosed prostate cancer. The software ruled out metastasis with confidence, whereas the positive predictive value was modest. The diagnostic properties were different for DICOM and Interfile file formats.
“…The file format issue is relevant when comparing data among sites and in serial scans if different file formats are used.The diagnostic properties of the computer-aided analysis program showed sensitivities and specificities of 90-100% with DICOM format files and 69-88% with Interfile formats. The high sensitivities and specificities are in line with previous reports[9,10,12,17]. Most studies with EXINI Bone BSI have been performed in patients with metastatic disease in whom the prevalence of metastasis varied from 15 to 40%[10,12,15].…”
supporting
confidence: 86%
“…The high sensitivities and specificities are in line with previous reports[9,10,12,17]. Most studies with EXINI Bone BSI have been performed in patients with metastatic disease in whom the prevalence of metastasis varied from 15 to 40%[10,12,15]. In clinical practice, the true reference is seldom known and the PPV and NPVs are of major importance.…”
supporting
confidence: 82%
“…EXINI Bone BSI is one such system with solid documentation [9][10][11][12]. The validation of computer-assisted software has mostly been performed in mixed patient populations with different types of cancer, in patients with a high prevalence for metastatic disease, in retrospective settings, and with limited sample sizes.…”
EXINI Bone(BSI) showed high sensitivity and specificity for bone metastasis in patients with newly diagnosed prostate cancer. The software ruled out metastasis with confidence, whereas the positive predictive value was modest. The diagnostic properties were different for DICOM and Interfile file formats.
“…However, the BSI was calculated from the weight and the fractional involvement of each bone, expressed as percentages of the entire skeleton; this is largely dependent upon each observer's visual evaluation (13). Following establishment of the CAD-based BONENAVI system for automatic calculation of the BSI, its usefulness in the diagnosis and monitoring of bone metastasis has been reported by several authors (11,14,15). BONENAVI is now routinely used during bone scans in various facilities, including our institution.…”
The purpose of the present study was to analyze the effect of treatment of Paget's disease of bone (PDB) with bone scintigraphy using a computer-assisted diagnosis system (BONENAVI) that quantitatively evaluates bone metabolism. Seven patients with PDB (three male, four female; average age, 60 years; age range, 33–80 years) underwent bone scintigraphy and measurement of serum alkaline phosphatase (ALP), bone-specific ALP (BAP), serum cross-linked N-telopeptide (NTx) of type I collagen, urinary NTx, and deoxypyridinoline (DPD) before and after bisphosphonate treatment. Bone scan index (BSI), artificial neural network (ANN) value, and hotspot number (HSn) were calculated using BONENAVI software. Mean follow-up period was 22 months (range, 11–35 months). Among three BONENAVI parameters (ANN, BSI, and HSn), only BSI was significantly lower after bisphosphonate treatment as compared with before. All bone metabolic markers excluding DPD were significantly lower following bisphosphonate treatment than before. Bone formation markers (ALP and BAP) were significantly lower than bone resorption markers (U-NTx and S-NTx). The correlation of BONENAVI parameters with four bone metabolic markers was analyzed before and after bisphosphonate treatment. Before treatment, the majority of the four markers did not correlate with the BONENAVI parameters. In contrast, post-treatment ALP, BAP, and U-NTx were significantly correlated with BSI and HSn. To the best of our knowledge, this is the first study to evaluate the treatment of PDB by bone scintigraphy using a computer-assisted diagnosis system that quantitatively evaluates bone metabolism. The findings demonstrated that, using BONENAVI software, bone scintigraphy is able to quantitatively and spatially evaluate the bisphosphonate treatment effect, particularly in patients with polyostotic PDB.
“…This approach, 'radiomics', can extract descriptions of intensity distribution, spatial relationships, and heterogeneity in shape and texture to characterize areas of interest such as tumors. It is built on the foundation of computer-aided diagnosis using medical imaging, for which algorithms have been developed for organs including the brain [82]; prostate, breast, and lung [83]; and bone [84]. The brain and cancers represent major areas of interest for development of biomarkers due to the need for noninvasive diagnosis and monitoring techniques [85].…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.